123 related articles for article (PubMed ID: 35997936)
1. JM-20, a Benzodiazepine-Dihydropyridine Hybrid Molecule, Inhibits the Formation of Alpha-Synuclein-Aggregated Species.
Santos CC; Cardim-Pires TR; Shvachiy L; Fonseca-Fonseca LA; Muñoz P; Almeida ÁMAN; Costa ACS; Teles-Souza J; Ochoa-Rodríguez E; de Fátima Dias Costa M; Palhano FL; Segura-Aguilar J; Barbosa DB; do Bomfim MR; Dos Santos Junior MC; Leite FHA; da Rocha Pita SS; Costa SL; Núñez-Figueredo Y; Outeiro TF; Foguel D; Silva VDA
Neurotox Res; 2022 Dec; 40(6):2135-2147. PubMed ID: 35997936
[TBL] [Abstract][Full Text] [Related]
2. JM-20 protects against 6-hydroxydopamine-induced neurotoxicity in models of Parkinson's disease: Mitochondrial protection and antioxidant properties.
Fonseca-Fonseca LA; da Silva VDA; Wong-Guerra M; Ramírez-Sánchez J; Yaquis ASP; Ochoa-Rodríguez E; Verdecia-Reyes Y; de Araújo FM; Santana RC; Outeiro TF; Costa SL; Núñez-Figueredo Y
Neurotoxicology; 2021 Jan; 82():89-98. PubMed ID: 33232743
[TBL] [Abstract][Full Text] [Related]
3. Alpha-Synuclein and GM1 Ganglioside Co-Localize in Neuronal Cytosol Leading to Inverse Interaction-Relevance to Parkinson's Disease.
Kumar R; Chowdhury S; Ledeen R
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542297
[TBL] [Abstract][Full Text] [Related]
4. Endosulfine-alpha inhibits membrane-induced α-synuclein aggregation and protects against α-synuclein neurotoxicity.
Ysselstein D; Dehay B; Costantino IM; McCabe GP; Frosch MP; George JM; Bezard E; Rochet JC
Acta Neuropathol Commun; 2017 Jan; 5(1):3. PubMed ID: 28069058
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector-Based Parkinson's Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain.
Svarcbahs R; Julku UH; Myöhänen TT
J Neurosci; 2016 Dec; 36(49):12485-12497. PubMed ID: 27927963
[TBL] [Abstract][Full Text] [Related]
6. JM-20, a novel hybrid molecule, protects against rotenone-induced neurotoxicity in experimental model of Parkinson's disease.
Fonseca-Fonseca LA; Wong-Guerra M; Ramírez-Sánchez J; Montano-Peguero Y; Padrón Yaquis AS; Rodríguez AM; da Silva VDA; Costa SL; Pardo-Andreu GL; Núñez-Figueredo Y
Neurosci Lett; 2019 Jan; 690():29-35. PubMed ID: 30304707
[TBL] [Abstract][Full Text] [Related]
7. The protective role of AMP-activated protein kinase in alpha-synuclein neurotoxicity in vitro.
Dulovic M; Jovanovic M; Xilouri M; Stefanis L; Harhaji-Trajkovic L; Kravic-Stevovic T; Paunovic V; Ardah MT; El-Agnaf OM; Kostic V; Markovic I; Trajkovic V
Neurobiol Dis; 2014 Mar; 63():1-11. PubMed ID: 24269733
[TBL] [Abstract][Full Text] [Related]
8. Reynosin protects against neuronal toxicity in dopamine-induced SH-SY5Y cells and 6-hydroxydopamine-lesioned rats as models of Parkinson's disease: Reciprocal up-regulation of E6-AP and down-regulation of α-synuclein.
Ham A; Kim DW; Kim KH; Lee SJ; Oh KB; Shin J; Mar W
Brain Res; 2013 Aug; 1524():54-61. PubMed ID: 23751361
[TBL] [Abstract][Full Text] [Related]
9. The small molecule alpha-synuclein misfolding inhibitor, NPT200-11, produces multiple benefits in an animal model of Parkinson's disease.
Price DL; Koike MA; Khan A; Wrasidlo W; Rockenstein E; Masliah E; Bonhaus D
Sci Rep; 2018 Nov; 8(1):16165. PubMed ID: 30385782
[TBL] [Abstract][Full Text] [Related]
10. Adenosine A2A Receptors Modulate α-Synuclein Aggregation and Toxicity.
Ferreira DG; Batalha VL; Vicente Miranda H; Coelho JE; Gomes R; Gonçalves FQ; Real JI; Rino J; Albino-Teixeira A; Cunha RA; Outeiro TF; Lopes LV
Cereb Cortex; 2017 Jan; 27(1):718-730. PubMed ID: 26534909
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of alpha-synuclein promotes both cell proliferation and cell toxicity in human SH-SY5Y neuroblastoma cells.
Rodríguez-Losada N; de la Rosa J; Larriva M; Wendelbo R; Aguirre JA; Castresana JS; Ballaz SJ
J Adv Res; 2020 May; 23():37-45. PubMed ID: 32071790
[TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein phosphorylation enhances eosinophilic cytoplasmic inclusion formation in SH-SY5Y cells.
Smith WW; Margolis RL; Li X; Troncoso JC; Lee MK; Dawson VL; Dawson TM; Iwatsubo T; Ross CA
J Neurosci; 2005 Jun; 25(23):5544-52. PubMed ID: 15944382
[TBL] [Abstract][Full Text] [Related]
13. The dopamine receptor agonist apomorphine stabilizes neurotoxic α-synuclein oligomers.
Lima VA; Esquinelato R; Carmo-Gonçalves P; Nascimento LAD; Lee H; Eliezer D; Romão L; Follmer C
FEBS Lett; 2022 Feb; 596(3):309-322. PubMed ID: 34928512
[TBL] [Abstract][Full Text] [Related]
14. Alpha-synuclein in Parkinson's disease: a villain or tragic hero? A critical view of the formation of α-synuclein aggregates induced by dopamine metabolites and viral infection.
Carmo-Gonçalves P; Coelho-Cerqueira E; de Araujo Lima V; Follmer C
Expert Rev Neurother; 2023 Apr; 23(4):321-330. PubMed ID: 37016954
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective effect of α-mangostin on mitochondrial dysfunction and α-synuclein aggregation in rotenone-induced model of Parkinson's disease in differentiated SH-SY5Y cells.
Hao XM; Li LD; Duan CL; Li YJ
J Asian Nat Prod Res; 2017 Aug; 19(8):833-845. PubMed ID: 28696167
[TBL] [Abstract][Full Text] [Related]
16. LMK235, a small molecule inhibitor of HDAC4/5, protects dopaminergic neurons against neurotoxin- and α-synuclein-induced degeneration in cellular models of Parkinson's disease.
Mazzocchi M; Goulding SR; Wyatt SL; Collins LM; Sullivan AM; O'Keeffe GW
Mol Cell Neurosci; 2021 Sep; 115():103642. PubMed ID: 34119632
[TBL] [Abstract][Full Text] [Related]
17. Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity.
Xiang W; Menges S; Schlachetzki JC; Meixner H; Hoffmann AC; Schlötzer-Schrehardt U; Becker CM; Winkler J; Klucken J
Mol Neurodegener; 2015 Mar; 10():8. PubMed ID: 25886189
[TBL] [Abstract][Full Text] [Related]
18. The food additive fast green FCF inhibits α-synuclein aggregation, disassembles mature fibrils and protects against amyloid-induced neurotoxicity.
Wang F; Wang Y; Jiang L; Wang W; Sang J; Wang X; Lu F; Liu F
Food Funct; 2021 Jun; 12(12):5465-5477. PubMed ID: 33997868
[TBL] [Abstract][Full Text] [Related]
19. Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons.
Pujols J; Peña-Díaz S; Lázaro DF; Peccati F; Pinheiro F; González D; Carija A; Navarro S; Conde-Giménez M; García J; Guardiola S; Giralt E; Salvatella X; Sancho J; Sodupe M; Outeiro TF; Dalfó E; Ventura S
Proc Natl Acad Sci U S A; 2018 Oct; 115(41):10481-10486. PubMed ID: 30249646
[TBL] [Abstract][Full Text] [Related]
20. Phosphorylation modulates clearance of alpha-synuclein inclusions in a yeast model of Parkinson's disease.
Tenreiro S; Reimão-Pinto MM; Antas P; Rino J; Wawrzycka D; Macedo D; Rosado-Ramos R; Amen T; Waiss M; Magalhães F; Gomes A; Santos CN; Kaganovich D; Outeiro TF
PLoS Genet; 2014 May; 10(5):e1004302. PubMed ID: 24810576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
